NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired common stock of Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK) between December 27, 2023, to May 6, 2025, inclusive. You are hereby notified that the class action lawsuit Judah Seidman v. Cytokinetics, Incorporated, et al. (Case No. 3:25-cv-07923) has been commenced in the United States District Court for t ...